Back to top
more

Auna S.A. (AUNA)

(Delayed Data from NYSE)

$6.20 USD

6.20
16,463

+0.03 (0.49%)

Updated Aug 4, 2025 02:27 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 246)

Industry: Medical Services

Zacks News

Zacks Equity Research

Auna S.A. (AUNA) Q1 Earnings Top Estimates

Auna S.A. (AUNA) delivered earnings and revenue surprises of 90% and 5.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

RenovoRx, Inc. (RNXT) Reports Q1 Loss, Lags Revenue Estimates

RenovoRx (RNXT) delivered earnings and revenue surprises of 0% and 1.50%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Auna S.A. (AUNA) Reports Next Week: What You Should Expect

Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Viatris (VTRS) Beats Q1 Earnings and Revenue Estimates

Viatris (VTRS) delivered earnings and revenue surprises of 2.04% and 0.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?

Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.

Zacks Equity Research

Cooper Companies Q1 Earnings Likely to Reflect Seasonal Trends

COO's fiscal first-quarter results are expected to follow seasonal trends, with a lighter start compared to the previous two reported quarters.

Zacks Equity Research

Canadian Natural to Report Q4 Earnings: What's in the Offing?

CNQ is expected to report lower revenues than the year-ago period. The company is anticipated to see a higher bottom line due to declining costs.

Zacks Equity Research

Is Auna S.A. (AUNA) Stock Outpacing Its Medical Peers This Year?

Here is how Auna S.A. (AUNA) and BioMarin Pharmaceutical (BMRN) have performed compared to their sector so far this year.

Zacks Equity Research

Sea Limited to Post Q4 Earnings: What's in Store for the Stock?

SE's fourth-quarter performance is likely to have benefited from strong Shopee and SeaMoney growth. Competition and FX volatility are expected to have hurt profitability.

Zacks Equity Research

Agilent Q1 Earnings Beat Estimates, Stock Falls on Cautious FY25 View

A's first-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.

Zacks Equity Research

Wall Street Analysts Predict a 39.33% Upside in Auna S.A. (AUNA): Here's What You Should Know

The mean of analysts' price targets for Auna S.A. (AUNA) points to a 39.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?

Here is how Auna S.A. (AUNA) and BioNTech SE Sponsored ADR (BNTX) have performed compared to their sector so far this year.